Abstract
An organism consisting of two or more organs of different genetic composition is an ancient concept. Greek, Indian, and Chinese mythologies provide abundant examples of mythical composite creatures with fantastic properties: the Greek Chimera, with three heads (lion, goat, and snake) and a body comprising a lion in the front, a goat in the rear, and snake for a tail; the Indian Ganesh, with the head of an elephant and a body of a man; and the Chinese Phoenix, which is a bird with the neck of a snake, the back of a tortoise, and the tail of a fish. By those standards, the goals of modern xenotransplantation are far less fanciful.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Evans, R. (1992). Need, demand, and supply in kidney transplantation: A review of the data, an examination of the issues, and projections through the year 2000.Semin. Nephrol.12, 234–255.
Stevenson, L., R. Kormos, R. Bourge, A. Gelijns, B. Griffith, R. Hershbergeret al.(2001). Mechanical cardiac support 2000: current applications and future trial design.J. Am. Coll. Cardiol.37, 340–370.
Kjaergard, L.L., J. Liu, B. Als-Nielsen, and C. Gluud (2003). Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic reviewJAMA289 217–222.
White, S.A. and M.L. Nicholson (1999). Xenotransplantation.Br. J. Surg.199, 1499–1514.
Reemtsma, K., B. McCracken, J. Schlegel, M. Pearl, C. Pearce, C. DeWillet al.(1964). Renal heterotransplantation from baboon to man.Ann. Surg.160, 384–408.
Starzl, T., J. Fung, A. Tzakis, S. Todo, A. Demetris, I. Marinoet al.(1993). Baboon-to-human liver transplantation.Lancet341, 65–71.
Dorling, A., K. Riesbeck, A. Warrens, and R. Lechler (1997). Clinical xenotransplantation of solid organs.Lancet349 867–871.
Caine, R. (1970). Organ transplantation between widely disparate species.Transplant. Proc.2 550–553.
Cascalho, M. and J.L. Platt (2001). The immunological barrier to xenotransplantation.Immunity14 437–446.
JiH.K. Ohmura, U. Mahmood, D.M. Lee, F.M. Hofhuis, S.A. Boackle et al. (2002). Arthritis critically dependent on innate immune system playersImmunity16 157–168.
Pangburn, M. (2000). Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complementImmunopharmacology49 149–157.
Good, A., D. Cooper, A. Malcolm, R. Ippolito, E. Koren, F. Neethinget al.(1992). Identification of carbohydrate structures that bind human antiporcine antibodies: Implication for discordant xenografting in humansTransplant. Proc42 559.
Galili, U. (1993). Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: A major obstacle for xenotransplantation in humansImmunol. Today14 480–482.
Galili, U. (1993). Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibodySpringer Semin. Immunopathol15 155–171.
Teranishi, K., R. Manez, M. Awwad, and D. Cooper (2002). Anti-Gal alpha 1–3Gal IgM and IgG antibody levels in sera of humans and old world non-human primatesXenotransplantation9 148–154.
Buonomano, R., C. Tinguely, R. Rieben, P. Mohacsi, and U. Nydegger (1999). Quantitation and characterization of anti-Galalphal-3Gal antibodies in sera of 200 healthy personsXenotransplantation6 173–180.
Galili, U., F. Anaraki, A. Thall, C. Hill-Black, and M. Radic (1993). One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody.Blood82, 2485–2493.
Galili, U., R. Mandrell, R. Hamandeh, S.B. Shohet, and J. Griffis (1988). Interaction between human natural anti-a-galactosyl immunoglobulin G and bacteria of the human floraInfect. Immun56 1730.
Yu, P.B. W. Parker, M.L. Everett, I.J. Fox, and J.L. Platt (1999). Immunochemical properties of anti-Gal alpha 1,3Gal antibodies after sensitization with xenogeneic tissuesJ. Clin. Immunol19 116–126.
Romo, G., J. Dong, A. Schade, E. Gardiner, G. Kansas, C. Liet al.(1999). The glycoprotein lb-IX-V complex is a platelet counterreceptor for P-selectin.J. Exp. Med.190, 803–814.
Kobayashi, T., S. Taniguchi, Y. Ye, M. Niekrasz, S. Kosanke, F. Neethlinget al.(1996). Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor.Transplant. Proc.28, 560.
Kirschfink, M. (2001). Targeting complement in therapy.Immunol. Rev.180, 177–189.
Fodor, W., S. Rollins, E. Guilmette, E. Setter, and S. Squinto (1995). A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complexJ. Immunol. 1554135–4138
Wang, H., S.A. Rollins, Z. Gao, B. Garcia, Z. Zhang, J. Xinget al.(1999). Complement inhibition with an anti-05 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model.Transplantation68, 1643–1651.
Fiane, A., T. Mollnes, V. Videm, T. Hovig, K. Hogasen, O. Mellbyeet al.(1999). Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.Xenotransplantation6, 52–65.
Cozzi, E., F. Bhatti, M. Schmoeckel, G. Chavez, K.G. Smith, A. Zaidiet al.(2000). Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts.Transplantation70, 15–21.
Byrne, G.W., K.R. McCurry, M.J. Martin, S.M. McClellan, J.L. Platt, and J.S. Logan (1997). Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.Transplantation63, 149–155.
McCurry, K., D. Kooyman, C. Alvarado, A. Cotterell, A. Martin, J. Loganet al.(1995). Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injuryNat. Med. 1423–427
Zhou, C., E. McInnes, N. Parsons, G. Langford, R. Lancaster, A. Richardset al.(2002). Production and characterization of a pig line transgenic for human membrane cofactor protein.Xenotransplantation9, 183–190.
Diamond, L.G., C.M. Quinn, M.J. Martin, J.L. Lawson, J.L. Platt, and J.S. Logan (2001). A human CD46 trans-genic pig model system for the study of discordant xenotransplantation.Transplantation71, 132–142.
Lin, S.S. and J.L. Platt (1996). Immunologic barriers to xenotransplantation.J. Heart Lung Transplant.15,547–555.
Lin, S., B. Weidner, G. Byrne, L. Diamond, J. Lawson, C. Hoopeset al.(1998). The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplantsJ. Clin. Invest. 1011745–1756
Lin, S.S., M.J. Hanaway, G.V. Gonzalez-Stawinski, C.L. Lau, W. Parker, R.D. Daviset al.(2000). The role of anti-Gal 1al-3Gal antibodies in acute vascular rejection and accommodation of xenografts.Transplantion70, 1667–1674.
Lin, S.S., D.L. Kooyman, L.J. Daniels, C.W. Daggett, W. Parker, J.H. Lawsonet al.(1997). The role of natural anti-Gal alpha 1–3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants.Transpl. Immunol.5, 212–218.
Taniguchi, S., F.A. Neethling, E.Y. Korchagina, N. Bovin, Y. Ye, T. Kobayashiet al.(1996). In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1–3Gal column.Transplantation62, 1379–1384.
Alwayn, I., M. Basker, L. Buhler, and D. Cooper (1999). The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies.Xenotransplantation6, 157–168.
Katopodis, A., R. Warner, R. Duthaler, M. Streiff, A. Bruelisauer, O. Kretzet al.(2002). Removal of antiGalalphal,3Gal xenoantibodies with an injectable polymerJ. Clin. Invest. 1101869–1877
Fryer, J., J. Leventhal, A. Dalmasso, S. Chen, P. Simone, J. Goswitzet al.(1995). Beyond hyperacute rejection: Accelerated rejection in a discordant xenograft model by adoptive transfer of specific subsets.Transplantation59, 171–176.
Leventhal, J., A. Matas, L. Sun, S. Reif, R. Bolman, A. Dalmassoet al.(1993). The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.Transplantation56, 1–8.
Goddard, M., J. Dunning, J. Horsley, C. Atkinson, G. Pino-Chavez, and J. Wallwork (2002). Histopathology of cardiac xenograft rejection in the pig-to-baboon model. J.Heart Lung Transplant.21, 474–484.
Kaplon, R.J., R.E. Michler, H. Xu, P.A. Kwiatkowski, N.M. Edwards, and J.L. Platt (1995). Absence of hyper-acute rejection in newborn pig-to-baboon cardiac xenografts.Transplantation59, 1–6.
Holzknecht, Z., K. Kuypers, T. Plummer, J. Williams, M. Bustos, G. Goreset al.(2002). Apoptosis and cellular activation in the pathogenesis of acute vascular rejection.Circ. Res.91, 1135–1141.
Xu, H., B. Naziruddin, D. Yin, J. Shen, J.S. Logan, G.W. Byrneet al.(2003). Functional characteristics of anti-Gal monoclonal antibodies: Correlation between in vitro and in vivo activity.1 Immunol.170, 1531–1539.
Foreman, K.E., A.A. Vaporciyan, B.K. Bonish, M.L. Jones, K.J. Johnson, M.M. Glovskyet al.(1994). C5a-induced expression of P-selectin in endothelial cells.J. Clin. Invest.94, 1147–1155.
Kozlowski, T., R. Monroy, Y. Xu, R. Glaser, M. Awwad, D. Cooper, and D. Sachs (1998). Anti-Gal (alpha) 1–3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction.Transplantation66, 176–182.
Galili, U., A. Tibell, B. Samuelsson, L. Rydberg, and C. Groth (1995). Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.Transplantation59, 1549–1556.
Buhler, L., M. Awwad, M. Basker, S. Gojo, A. Watts, S. Treter (2000). High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.Transplantation69, 2296–2304.
Diamond, L., G. Byrne, A. Schwarz, T. Davis, D. Adams, and J. Logan (2002). Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha]-3 galactose trisaccharide-polyethylene glycol conjugateTransplantation73 1780–1787.
Teranishi, K., B. Gollackner, L. Buhler, C. Knosalla, L. Correa, J. Downet al.(2002). Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides.Transplantation73, 129–139.
Thall, A., P. Maly, and J. Lowe (1995). Oocyte Galal,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse.J. Biol. Chem.270, 21437–21440.
Tearle, R., M. Tange, Z. Zannettino, M. Katerelos, T. Shinkel, B. van Denderenet al.(1996). The a1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation.Transplantation61, 13–19.
Campbell, K., J. McWhir, W. Ritchie, and I. Wilmut (1996). Sheep cloned by nuclear transfer from a cultured cell line.Nature380, 64–66.
Polejaeva, I., S. Chen, T. Vaught, R. Page, J. Mullins, S. Ballet al.(2000). Cloned pigs produced by nuclear transfer from adult somatic cells.Nature407, 86–90.
Baguisi, A., E. Behboodi, D. Melican, J. Pollock, M. Destrempes, C. Cammusoet al.(1999). Production of goats by somatic cell nuclear transfer.Nat. Biotechnol.17, 456–461.
Cibelli, J., S. Stice, P. Golueke, J. Kane, J. Jerry, C. Blackwellet al.(1998). Cloned transgenic calves produced from nonquiescent fetal fibroblasts.Science280, 1256–1258.
Wakayama, T., I. Rodriguez, A. Perry, R. Yanagimachi, and P. Mombaerts (1999). Mice cloned from embryonic stem cells.Proc. Natl. Acad. Sci. USA96, 14984–14989.
Onishi, A., M. Iwamoto, T. Akita, S. Mikawa, K. Takeda, T. Awataet al.(2000). Pig cloning by microinjection of fetal fibroblast nuclei.Science289, 1188–1190.
McCreath, K., J. Howcroft, K. Campbell, A. Colman, A. Schnieke, and A. Kind (2000). Production of gene-targeted sheep by nuclear transfer from cultured somatic cells.Nature405, 1066–1069.
Bondioli K., J. Ramsoondar, B. Williams, C. Costa, and W. Fodor (2001). Cloned pigs generated from cultured skin fibroblasts derived from a H-transferase transgenic boar.Mol. Reprod. Dev.60, 189–195.
Dai, Y., T. Vaught, J. Boone, S. Chen, C. Phelps, S. Ballet al.(2002). Targeted disruption of the alphal, 3-galactosyltransferase gene in cloned pigs.Nat. Biotechnol.20, 251–255.
Lai, L., D. Kolber-Simonds, K.W. Park, H.T. Cheong, J.L. Greenstein, G.S. Imet al.(2002). Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.Science295, 1089–1092.
Phelps, C.J., C. Koike, T.D. Vaught, J. Boone, K.D. Wells, S.-H. Chenet al.(2002). Production of a1,3Galactosyltransferase-deficient pigs.Science299, 411–414.
Patience, C., Y. Takeuchi, and R. Weiss (1997). Infection of human cells by an endogenous retrovirus of pigs.Nat. Med.3, 282–286.
Paradis, K., G. Langford, Z. Long, W. Heneine, P. Sandstrom, W. Switzeret al.(1999). Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.Science285, 1236–1241.
van der Laan, L., C. Lockey, B. Griffeth, E Frasier, C. Wilson, D. Onionset al.(2000). Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice.Nature407, 90–94.
Rother, R., W. Fodor, J. Springhorn, C. Birks, E. Setter, M. Sandrinet al.(1995). A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.J. Exp. Med.182, 1345–1355.
Platt, J.L. (2000). Xenotransplantation. New risks, new gains.Nature27, 29–30.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chong, A.S., Boussy, I.A., Byrne, G.W. (2004). Xenotransplantation. In: Wilkes, D.S., Burlingham, W.J. (eds) Immunobiology of Organ Transplantation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8999-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8999-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4754-5
Online ISBN: 978-1-4419-8999-4
eBook Packages: Springer Book Archive